Dale Miles

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 17

Top Topics

Endoplasmic Reticulum

Hodgkin Lymphoma

Top Venues

CPT: pharmacometrics & systems pharmacology

NPJ systems biology and applications

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Clinical pharmacology and therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Hardik Mody, Dhruvitkumar S Sutaria, Dale Miles
Clinical Pharmacology Considerations for the "Off-the-Shelf" Allogeneic Cell Therapies. Clinical pharmacology and therapeutics (2024)
Sharon P Shriver, Devon Adams, Brittany Avin McKelvey, Jeannine S McCune, Dale Miles, Victoria M Pratt, Kristine Ashcraft, Howard L McLeod, Hannah E Williams, Mark E Fleury
Overcoming Barriers to Discovery and Implementation of Equitable Pharmacogenomic Testing in Oncology. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (10) (2024)
Rong Deng, Leonid Gibiansky, Tong Lu, Christopher R Flowers, Laurie H Sehn, Qi Liu, Priya Agarwal, Michael Z Liao, Randall Dere, Calvin Lee, Gabriel Man, Jamie Hirata, Chunze Li, Dale Miles
Population pharmacokinetics and exposure-response analyses of polatuzumab vedotin in patients with previously untreated DLBCL from the POLARIX study. CPT: pharmacometrics & systems pharmacology 13 (6) (2024)
Louis R Joslyn, Weize Huang, Dale Miles, Iraj Hosseini, Saroja Ramanujan
"Digital twins elucidate critical role of T scm in clinical persistence of TCR-engineered cell therapy". NPJ systems biology and applications 10 (1) (2024)
Louis R Joslyn, Weize Huang, Dale Miles, Iraj Hosseini, Saroja Ramanujan
"Digital twins elucidate critical role of T scm in clinical persistence of TCR-engineered cell therapy". NPJ systems biology and applications 10 (1) (2024)
Rong Deng, Leonid Gibiansky, Tong Lu, Christopher R Flowers, Laurie H Sehn, Qi Liu, Priya Agarwal, Michael Z Liao, Randall Dere, Calvin Lee, Gabriel Man, Jamie Hirata, Chunze Li, Dale Miles
Population pharmacokinetics and exposure-response analyses of polatuzumab vedotin in patients with previously untreated DLBCL from the POLARIX study. CPT: pharmacometrics & systems pharmacology 13 (6) (2024)
Louis R Joslyn, Weize Huang, Dale Miles, Iraj Hosseini, Saroja Ramanujan
"Digital twins elucidate critical role of T scm in clinical persistence of TCR-engineered cell therapy". NPJ systems biology and applications 10 (1) (2024)
Hardik Mody, Dhruvitkumar S Sutaria, Dale Miles
Clinical Pharmacology Considerations for the "Off-the-Shelf" Allogeneic Cell Therapies. Clinical pharmacology and therapeutics 115 (6) (2024)
Hardik Mody, Dhruvitkumar S Sutaria, Dale Miles
Clinical Pharmacology Considerations for the "Off-the-Shelf" Allogeneic Cell Therapies. Clinical pharmacology and therapeutics 115 (6) (2024)
Sharon P Shriver, Devon Adams, Brittany Avin McKelvey, Jeannine S McCune, Dale Miles, Victoria M Pratt, Kristine Ashcraft, Howard L McLeod, Hannah E Williams, Mark E Fleury
Overcoming Barriers to Discovery and Implementation of Equitable Pharmacogenomic Testing in Oncology. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Louis R Joslyn, Weize Huang, Dale Miles, Iraj Hosseini, Saroja Ramanujan
"Digital twins elucidate critical role of T scm in clinical persistence of TCR-engineered cell therapy". NPJ systems biology and applications 10 (1) (2024)
Sharon P Shriver, Devon Adams, Brittany Avin McKelvey, Jeannine S McCune, Dale Miles, Victoria M Pratt, Kristine Ashcraft, Howard L McLeod, Hannah E Williams, Mark E Fleury
Overcoming Barriers to Discovery and Implementation of Equitable Pharmacogenomic Testing in Oncology. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (10) (2024)
Rong Deng, Leonid Gibiansky, Tong Lu, Christopher R Flowers, Laurie H Sehn, Qi Liu, Priya Agarwal, Michael Z Liao, Randall Dere, Calvin Lee, Gabriel Man, Jamie Hirata, Chunze Li, Dale Miles
Population pharmacokinetics and exposure-response analyses of polatuzumab vedotin in patients with previously untreated DLBCL from the POLARIX study. CPT: pharmacometrics & systems pharmacology 13 (6) (2024)
Rong Deng, Leonid Gibiansky, Tong Lu, Christopher R Flowers, Laurie H Sehn, Qi Liu, Priya Agarwal, Michael Z Liao, Randall Dere, Calvin Lee, Gabriel Man, Jamie Hirata, Chunze Li, Dale Miles
Population pharmacokinetics and exposure-response analyses of polatuzumab vedotin in patients with previously untreated DLBCL from the POLARIX study. CPT: pharmacometrics & systems pharmacology (2024)
Hardik Mody, Ken Ogasawara, Xu Zhu, Dale Miles, Prathap Nagaraja Shastri, Jochem Gokemeijer, Michael Z Liao, Sreeneeranj Kasichayanula, Tong-Yuan Yang, Nagendra Chemuturi, Swati Gupta, Vibha Jawa, Vijay V Upreti
Best Practices & Considerations for Clinical Pharmacology & Pharmacometric Aspects for Optimal Development of CAR-T & TCR-T Cell Therapies: An Industry Perspective. Clinical pharmacology and therapeutics (2023)
Othman Al-Sawaf, Can Zhang, Tong Lu, Michael Z Liao, Anesh Panchal, Sandra Robrecht, Travers Ching, Maneesh Tandon, Anna-Maria Fink, Eugen Tausch, Christof Schneider, Matthias Ritgen, Sebastian Böttcher, Karl-Anton Kreuzer, Brenda Chyla, Dale Miles, Clemens-Martin Wendtner, Barbara Eichhorst, Stephan Stilgenbauer, Yanwen Jiang, Michael Hallek, Kirsten Fischer
Minimal Residual Disease Dynamics after Venetoclax-Obinutuzumab Treatment: Extended Off-Treatment Follow-up From the Randomized CLL14 Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2021)
Dan Lu, Tong Lu, Leonid Gibiansky, Xiaobin Li, Chunze Li, Priya Agarwal, Colby S Shemesh, Rong Shi, Randall C Dere, Jamie Hirata, Dale Miles, Pascal Chanu, Sandhya Girish, Jin Yan Jin
Integrated Two-Analyte Population Pharmacokinetic Model of Polatuzumab Vedotin in Patients With Non-Hodgkin Lymphoma. CPT: pharmacometrics & systems pharmacology 9 (1) (2019)